Innoviva Set to Join the S&P SmallCap 600

NEW YORK, Nov. 7, 2016

Innoviva engages in the development and commercialization of bio-pharmaceuticals. Headquartered in South San Francisco, CA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Pharmaceuticals Sub-Industry index.

Following is a summary of the change:

S&P SMALLCAP 600 INDEX – November 9, 2016
	COMPANY	GICS ECONOMIC SECTOR	GICS SUB-INDUSTRY ARIVA.DE Börsen-Geflüster Kurse Coherent -   0,00% Innoviva 13,70 € 0,00% Rofin Sinar -   0,00% S&P Global 388,75 € -0,68%
ADDED	Innoviva	Healthcare	Pharmaceuticals
DELETED	Rofin-Sinar Technologies	Information Technology	Electronic Equipment & Instruments

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than based on any other provider in the world. With over 1,000,000 indices and more than 120 years of experience constructing innovative and transparent solutions, S&P Dow Jones Indices defines the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

David Blitzer
Managing Director and Chairman of the Index Committee 
New York, USA
(+1) 212 438 3907
david.blitzer@spdji.com

Luke Shane
Communications Manager 
New York, USA 
(+1) 212 438 8184 
luke.shane@spglobal.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innoviva-set-to-join-the-sp-smallcap-600-300358763.html

SOURCE S&P Dow Jones Indices